Clinical Trial Update: Quetiapine in Postpartum Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of quetiapine for postpartum depression was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Depression

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Postpartum Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2010-09-17